|
|
Anish Suri, James J. Walters, Michael L. Gross, Emil R. Unanue
J Clin Invest. 2005;
115(8):2268
doi:10.1172/JCI25350
Abstract |
Full text
| PDF
| Supplemental material

I
n this study, a large number of naturally processed peptides was isolated and identified from the human diabetes-susceptible class II MHC molecules HLA-DQ8 (DQA1*0301,DQB1*0302) and from murine I-Ag7 species, both of which are expressed in genetically identical APC lines. The peptides presented during the processing of autologous proteins were highly selective in showing sequence specificity, mainly consisting of 1 or more acidic residues at their C terminus. Testing for binding to the MHC molecules revealed that the position 9 (P9) acidic residues of the peptides contributed decisively to binding. For HLA-DQ8, the P1 residue, which was also an acidic amino acid, influenced binding positively. Both HLA-DQ8 and I-Ag7 selected for common peptides that bound in the same register. There was no evidence for selection of peptides having nonspecific or promiscuous binding. Thus, diabetogenic class II MHC molecules are highly selective in terms of the peptides presented by their APCs, and this is governed by the features of their P9 anchor pocket. These results are in striking contrast to those from studies examining synthetic peptide or phage display libraries, in which many peptides were shown to bind.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(27)
| Title and authors |
Publication |
Year |
Pharmacotherapy and management strategies for coeliac disease
Suzanne C Donnelly, H Julia Ellis, Paul J Ciclitira
|
Expert Opin. Pharmacother.
|
2011 |
Impaired thymic tolerance to α-myosin directs autoimmunity to the heart in mice and humans
HuiJuan Lv, Evis Havari, Sheena Pinto, Raju V.S.R.K. Gottumukkala, Lizbeth Cornivelli, Khadir Raddassi, Takashi Matsui, Anthony Rosenzweig, Roderick T. Bronson, Ross Smith, Anne L. Fletcher, Shannon J. Turley, Kai Wucherpfennig, Bruno Kyewski, Myra A. Lipes
|
J. Clin. Invest.
|
2011 |
Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope
C. Daniel, B. Weigmann, R. Bronson, H. von Boehmer
|
Journal of Experimental Medicine
|
2011 |
The peptide-binding motif of HLA-DR8 shares important structural features with other type 1 diabetes-associated alleles
L Muixí, M Gay, P M Muñoz-Torres, C Guitart, J Cedano, J Abian, I Alvarez, D Jaraquemada
|
Genes Immun
|
2011 |
Mass Spectrometry of Antigenic Peptides
Henry Rohrs
|
Protein and Peptide Mass Spectrometry in Drug Discovery Gross/Protein Mass Spec Drug Discovery
|
2011 |
Register shifting of an insulin peptide-MHC complex allows diabetogenic T cells to escape thymic deletion
J. F. Mohan, S. J. Petzold, E. R. Unanue
|
Journal of Experimental Medicine
|
2011 |
Insulin as a key autoantigen in the development of type 1 diabetes
Maki Nakayama
|
Diabetes Metab. Res. Rev.
|
2011 |
An update on the use of NOD mice to study autoimmune (Type 1) diabetes
Rodolfo José Chaparro, Teresa P DiLorenzo
|
Expert Rev Clin Immunol
|
2010 |
The prolonged and enhanced immune response in the non-obese diabetic mouse is dependent on genes in the Idd1/24, Idd12 and Idd18 regions
Mia Sundström, Kristina Lejon
|
Journal of Autoimmunity
|
2010 |
Etiology of Type 1 Diabetes
John A. Todd
|
Immunity
|
2010 |
|